Navigation Links
Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
Date:8/19/2007

WHITE PLAINS, N.Y., AUG. 2 /PRNewswire-USNewswire/ -- Two major studies published today in The New England Journal of Medicine can help doctors better identify pregnant women at risk for preterm delivery who can benefit from progesterone treatment, the March of Dimes Foundation said today.

In one large multi-center trial led by Eduardo B. Fonseca, M.D., women with short cervix (most of whom had no prior history of preterm birth) who received progesterone suppository treatment between 24 and 34 weeks gestation had a greatly reduced rate of preterm birth.

Another large multi-center trial led by Dwight J. Rouse, M.D., found that weekly injections of 17P (17 alpha-hydroxyprogesterone caproate, a derivative of progesterone) between 16 and 35 weeks gestation did not reduce the rate of preterm birth among women carrying twins.

"Premature birth is a growing problem in the United States and a leading killer of newborns," said Michael Katz, senior vice president for Research and Global Programs of the March of Dimes. "With this new information, physicians will have a better idea of how to identify those women who are most likely to benefit from progesterone treatment from those who are not."

Dr. Katz noted that pathways to preterm birth may differ substantially between singleton and twin gestations. For example, progesterone may be more effective against some pathway that does not involve the uterine over- distention seen in twin pregnancy.

"We need more research into the underlying causes of prematurity to help women with other risk factors," Dr. Katz said.

In previous studies (Meis et al., NEJM, 2003;348:2379-85; da Fonseca et al., Am J Ob Gyny, 2003;188:419-24), the benefit of progesterone was seen in women with singleton pregnancies and a documented history of a previous spontaneous preterm birth. These study results led to a Committee Opinion issued by the American College of Obstetricians and Gynecologists on the use of progest
'/>"/>

SOURCE March of Dimes Foundation

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
7. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
8. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
9. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
10. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
11. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... AMD LASERS just announced that in...e, has accepted the position of Medical Director. ...r overseeing research and development of new soft ...iance for continuing education credits, authoring ...ations, and lecturing and seminar engagements. ,...
(Date:11/9/2009).... 9 Access MediQuip, LLC, the nati...antable medical device management solutions to the...elocating its corporate headquarters to Lake Mary,...ued rapid growth, includes a major expansion of th...pen in January 2010 and relocation and expansion o...
(Date:11/9/2009)...v. 9 Thomson Reuters today annou...Focus, a leading clinical surveillance solution th...in real-time and respond immediately to improve cl... ,, This upgrade is available to current CareFo...ocus 2.0 contains several powerful enhancements th...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 1HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 3Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 1Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 2Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 3Statement from Senators Daschle and Dole 59109 1
...NAPOLIS, Feb. 26 America,s pharmaceutical researc... number of potential medicines to treat two of the...port by the Pharmaceutical Research and Manufactur...h pipeline, over 300 new medicines are in developm... report reflects the never-ending commitment of ou...
...ubset analysis of bortezomib-relapsed patient popu...extended time to progression , , NEW YORK, Feb. 2...) today announced updated clinical results from an...in combination with bortezomib (+/- dexamethasone)...loma. The data, which was presented earlier today ...
Other Medicine Technology:Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 2Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 3Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 4
(Date:11/9/2009)...wswire/ -- Sutter Health, a family of doctors, not...e providers, is donating $255,000 to food banks ac...banks will share the quarter-million-dollar donati...thousands of families across the north state. ,... with and supporting charitable programs and servi...
(Date:11/9/2009)...gs that inhibit estrogen, , , MONDAY, N...breast cancer and osteoporosis eliminated cervical...e drugs also cleared precancerous growths in the c...r in mice with precancerous lesions. , The brea...steoporosis drug raloxifene were given to mice gen...
(Date:11/9/2009)...conditions are age-related, researchers say , ...t surgery doesn,t appear to speed the progression ...ng to a new study that challenges the belief that ...r. , "Because both conditions are strongly age-...AMD," wrote Li Ming Dong, of Stony Brook Universit...
(Date:11/9/2009)...ire-FirstCall/ - Hard To Treat Diseases (HTDS.PK) ...is, a US$41 billion international healthcare compa...e partner, Zhejiang Tianyuan Bio-Pharmaceutical Co...nd will begin a five-year, $1 billion China initia...increase its investment in its China R&D facil...
(Date:11/9/2009)...r Network (NCCN) has posted a draft white paper fo... near-term comparative effectiveness clinical eval...roduces the NCCN Comparative Therapeutic Index(TM)...e risk-versus-benefit of different treatment optio...lines in Oncology(TM). The paper will be posted fo...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...n Medical School, an injectable gel may be useful ... neck squamous cell carcinoma affects about 20,000...rug cisplatin has been shown to be an effective th...died 120 patients who were previously treated for ...
...found that eating more calories and fats may incre...some people. Previous research has shown that mice.... //Researchers feel this is because of fewer dest...se the damage done by particles found in brains of...
...bout life may not only help you live longer, it ma...he University of Illinois, found two years ago tha...same group of researchers// looked to see if one's...ermined who was optimistic, pessimistic or a mixtu...
...eneficial to our body. When sweet corn is heated, ..., and thereby making it a very healthy addition to...onception that boiling or steaming vegetables and ...nt power than you lose on cooking. For vitam...
...ely poor diet, which adds to the health risks of p...hand smoke accounts for up to 24 per cent of lung ...e smoking - usually because they live with a smoke...in their new survey, that many people living with ...
...because they really don't have allergies," said Sh...of pharmacy at Ohio State University. "They're oft...roblem."// A recent study of 246 patients showed ...rgies; the blood samples from only 35 percent of t...
Other Medicine News:Health News:Diet combined to Alzheimer's disease 2
Myoglobin ELISA
...for the quantitative determination of prolactin in...s and treatment of disorders of the anterior pitui...titative Test is based on the principle of a solid...y system utilized sheep anti-prolactin for solid p...
Prolactin EIA kit
... kit for the quantitative determination of Human P...noassay (EIA) permits the routine quantitative det... and provides an accurate, sensitive, reproducible...y method makes it possible to measure low concentr...
Medicine Products: